Large-scale testing (Phase 3)Looking for participantsNCT06994650
What this trial is testing
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Who Are on Positive Airway Pressure Ventilation (PAP) Therapy
Who this might be right for
Subjects With Moderate-to-severe OSA and Obesity Who Are on PAP Therapy
Fujian Shengdi Pharmaceutical Co., Ltd. 140